Literature DB >> 26871672

Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.

Caterina Conti1,2, Angeles Montero-Fernandez3, Elaine Borg4, Tina Osadolor3, Patrizia Viola3, Angelo De Lauretis1, Carmel J Stock1, Martina Bonifazi1, Matteo Bonini1, Gaetano Caramori5, Gisela Lindahl1, Francesco B Blasi2, Andrew G Nicholson3, Athol U Wells1, Piersante Sestini6, Elisabetta Renzoni1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26871672     DOI： 10.1164/rccm.201507-1322LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

1.  Looking at the Airway to Understand Interstitial Lung Disease.

Authors:  Justin M Oldham
Journal:  Ann Am Thorac Soc       Date:  2019-04

2.  Update in Interstitial Lung Disease 2016.

Authors:  Athol U Wells; Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

3.  Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Authors:  Ezra R Miller; Rachel K Putman; Alejandro A Diaz; Hanfei Xu; Raúl San José Estépar; Tetsuro Araki; Mizuki Nishino; Sergio Poli de Frías; Tomoyuki Hida; James Ross; Harvey Coxson; Josée Dupuis; George T O'Connor; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu; George Washko; Gary M Hunninghake
Journal:  Ann Am Thorac Soc       Date:  2019-04

4.  Muc5b plays a role in the development of inflammation and fibrosis in hypersensitivity pneumonitis induced by Saccharopolyspora rectivirgula.

Authors:  Tsukasa Okamoto; Evgenia Dobrinskikh; Corinne E Hennessy; Naoko Liu; Marvin I Schwarz; Christopher M Evans; Andrew P Fontenot; Ivana V Yang; David A Schwartz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-07-26       Impact factor: 6.011

Review 5.  Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases.

Authors:  Joanna Y Wang; Lisa R Young
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

Review 6.  Molecular Markers and the Promise of Precision Medicine for Interstitial Lung Disease.

Authors:  Chad A Newton; Erica L Herzog
Journal:  Clin Chest Med       Date:  2021-06       Impact factor: 4.967

7.  The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.

Authors:  Brett Ley; Chad A Newton; Isabel Arnould; Brett M Elicker; Travis S Henry; Eric Vittinghoff; Jeffrey A Golden; Kirk D Jones; Kiran Batra; Jose Torrealba; Christine Kim Garcia; Paul J Wolters
Journal:  Lancet Respir Med       Date:  2017-06-22       Impact factor: 30.700

Review 8.  Cell-Based Therapies for Tissue Fibrosis.

Authors:  Rebecca Lim; Sharon D Ricardo; William Sievert
Journal:  Front Pharmacol       Date:  2017-09-22       Impact factor: 5.810

9.  Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.

Authors:  Dinesh Khanna; Donald P Tashkin; Christopher P Denton; Elisabetta A Renzoni; Sujal R Desai; John Varga
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

10.  Localization of Secretory Mucins MUC5AC and MUC5B in Normal/Healthy Human Airways.

Authors:  Kenichi Okuda; Gang Chen; Durai B Subramani; Monroe Wolf; Rodney C Gilmore; Takafumi Kato; Giorgia Radicioni; Mehmet Kesimer; Michael Chua; Hong Dang; Alessandra Livraghi-Butrico; Camille Ehre; Claire M Doerschuk; Scott H Randell; Hirotoshi Matsui; Takahide Nagase; Wanda K O'Neal; Richard C Boucher
Journal:  Am J Respir Crit Care Med       Date:  2019-03-15       Impact factor: 30.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.